289 related articles for article (PubMed ID: 8501153)
41. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
42. Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL
Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
[TBL] [Abstract][Full Text] [Related]
43. Endocrine and metabolite responses to porcine growth hormone administered by sustained release implant for different lengths of time in male pigs.
Klindt J; Buonomo FC; Wise T; Yen JT
Endocrinology; 1996 Sep; 137(9):3689-95. PubMed ID: 8756534
[TBL] [Abstract][Full Text] [Related]
44. Response to IGF-1 Generation Test in Short Prepubertal Children Born Very Preterm or at Term.
Miles HL; Derraik JG; Chiavaroli V; Hofman PL; Cutfield WS
Horm Res Paediatr; 2015; 84(5):298-304. PubMed ID: 26347273
[TBL] [Abstract][Full Text] [Related]
45. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study.
Attie KM; Carlsson LM; Rundle AC; Sherman BM
J Pediatr; 1995 Aug; 127(2):244-50. PubMed ID: 7636649
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of insulin-like growth factor-I in short stature.
Park MS; Kim DH
Yonsei Med J; 1989 Dec; 30(4):367-75. PubMed ID: 2626840
[TBL] [Abstract][Full Text] [Related]
47. Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children.
Bjarnason R; Albertsson-Wikland K; Carlsson LM
J Clin Endocrinol Metab; 1995 Sep; 80(9):2756-60. PubMed ID: 7673420
[TBL] [Abstract][Full Text] [Related]
48. The measurement of insulin-like growth factor I: clinical applications and significance.
Teale JD; Marks V
Ann Clin Biochem; 1986 Jul; 23 ( Pt 4)():413-24. PubMed ID: 3094423
[TBL] [Abstract][Full Text] [Related]
49. Idiopathic short stature and growth hormone sensitivity in prepubertal children.
Derraik JGB; Miles HL; Chiavaroli V; Hofman PL; Cutfield WS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):110-117. PubMed ID: 30908679
[TBL] [Abstract][Full Text] [Related]
50. Effect of growth hormone on the low level of growth hormone binding protein in idiopathic short stature.
Fontoura M; Mugnier E; Brauner R; Rappaport R; Postel-Vinay MC
Clin Endocrinol (Oxf); 1992 Sep; 37(3):249-53. PubMed ID: 1424207
[TBL] [Abstract][Full Text] [Related]
51. Serum growth hormone-binding protein is decreased in prepubertal children with idiopathic short stature.
Dávila N; Moreira-Andrés M; Alcañiz J; Barceló B
J Endocrinol Invest; 1996 Jun; 19(6):348-52. PubMed ID: 8844453
[TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factor-I in children with short stature.
Tsai WY; Lee JS
J Formos Med Assoc; 1994 Sep; 93(9):810-2. PubMed ID: 7735013
[TBL] [Abstract][Full Text] [Related]
53. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type).
Walker JL; Van Wyk JJ; Underwood LE
J Pediatr; 1992 Oct; 121(4):641-6. PubMed ID: 1403403
[TBL] [Abstract][Full Text] [Related]
54. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
55. Serum ghrelin concentrations are increased in children with growth hormone insensitivity and decrease during long-term insulinlike growth factor-I treatment.
Uckun-Kitapci A; Haqq AM; Purnell JQ; Newcomb K; Gulkesen H; Underwood LE
J Investig Med; 2008 Jan; 56(1):26-31. PubMed ID: 18317425
[TBL] [Abstract][Full Text] [Related]
56. Effect of timing of growth hormone administration on plasma growth-hormone-binding activity, insulin-like growth factor-I and growth in children with a subnormal spontaneous secretion of growth hormone.
Zadik Z; Lieberman E; Altman Y; Chen M; Limoni Y; Landau H
Horm Res; 1993; 39(5-6):188-91. PubMed ID: 8314201
[TBL] [Abstract][Full Text] [Related]
57. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations.
Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Diamond FB; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Feb; 76(2):417-23. PubMed ID: 7679400
[TBL] [Abstract][Full Text] [Related]
58. Overnight growth hormone concentrations are usually normal in pubertal children with idiopathic short stature--a Clinical Research Center study.
Rose SR; Municchi G; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1996 Mar; 81(3):1063-8. PubMed ID: 8772577
[TBL] [Abstract][Full Text] [Related]
59. Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients.
Wolthers T; Grøfte T; Jørgensen JO; Møller N; Vahl N; Christiansen JS; Vilstrup H
J Clin Endocrinol Metab; 1994 May; 78(5):1220-4. PubMed ID: 7513718
[TBL] [Abstract][Full Text] [Related]
60. The role of recombinant human insulin-like growth factor-I in treating children with short stature.
Collett-Solberg PF; Misra M;
J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
